May 5, 2020
Bicycle Therapeutics doses first patient in Phase I dose escalation of its toxin conjugate with Nivolumab
– Monotherapy Phase I dose escalation remains ongoing; BT5528 appears well-tolerated as dosing approaches clinically relevant levels – BT5528 is…